Montag & Associates’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3K Buy
586
+77
+15% +$1.73K ﹤0.01% 730
2026
Q1
$11.5K Buy
+509
New +$11.7K ﹤0.01% 739
2025
Q4
– Sell
-22
Closed -$580 – 1034
2025
Q3
$580 Buy
+22
New +$566 ﹤0.01% 1071
2023
Q1
– Sell
-103
Closed -$1.68K – 941
2022
Q4
$1.68K Buy
+103
New +$1.53K ﹤0.01% 875

Other funds holding FMS

Montag & Associates's FMS Position: Q2 2026 in Review

Montag & Associates increased its Fresenius Medical Care (FMS) stake by 15% in Q2 2026, buying an estimated $1.73K and bringing the position to 586 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Montag & Associates first reported a position in FMS in Q4 2022 and has held it in 4 quarters since. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Montag & Associates held 586 shares of Fresenius Medical Care worth $13.3K as of Q2 2026.
  • Montag & Associates bought 77 Fresenius Medical Care shares in Q2 2026, an estimated $1.73K.
  • Fresenius Medical Care made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #730 holding.
  • Montag & Associates first reported a position in Fresenius Medical Care in Q4 2022 and has held it in 4 quarters since.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.